Robert Redd

20PUBLICATIONS
94CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAllergyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jun 23, 2026
SAVE, Safe Accelerated Venetoclax Escalation: A phase Ib study of obinutuzumab plus venetoclax with daily ramp-up in CLL.

|Mar 26, 2026
A phase 1/2 study of duvelisib plus venetoclax in patients with relapsed/refractory CLL/SLL or Richter transformation.

Jennifer L Crombie, Christine E Ryan, Yue Ren

|Mar 03, 2026
Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma.

Jennifer L Crombie, Sairah Ahmed, Matthew J Frigault

|Oct 31, 2025
A retrospective study of treatment and outcomes in synchronous systemic and central nervous system large B-cell lymphoma.

J Erika Haydu, Robert A Redd, Matthew M Lei

|Apr 03, 2025
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.

James T Yoon, Yinglu Zhou, Mariia Mikhaleva

|Feb 10, 2025
Single-cell dynamics of breakthrough toxicities after anakinra prophylaxis for axicabtagene ciloleucel in lymphoma.

Matthew J Frigault, Ning Yao, Trisha R Berger

Pageof 4

Frequent Collaborators

7 joint publications

Jennifer R Brown

6 joint publications

Ann S LaCasce

5 joint publications

Alex Herrera

4 joint publications

Austin I Kim